Integrating oncogenetics testing into African clinics and cancer control programs

African Oncogenetics Network: improving training and infrastructure in low-resource regions

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

The aims of the African Oncogenetics Network

MRD validated as a surrogate endpoint for survival in AML

IP6K1-driven tumour polyphosphate may contribute to immune checkpoint inhibitor-associated thrombosis

Exploring genomic insights in acute lymphoblastic leukaemia treatment

AI-Based sTIL analysis expands identification of HER2+ BC patients benefiting from pertuzumab

New genomic map of adult B-ALL identifies CEBPalt subgroup and highlights blinatumomab benefits in key high-risk molecular types

Empowering cancer care in Africa

Do all hormone sensitive prostate cancers need triplet therapy?

Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapy